Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05327686
Title Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study (SAMURAI)
Acronym SAMURAI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NRG Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.